AQST AQUESTIVE THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  7 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in AQUESTIVE THERAPEUTICS INC (AQST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2023 Q2)
Avg. % of fund
0.02%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 60,776 +46,142 +315.3% 0.02% $340K $5.59
2025 Q2 REDUCED 14,634 -63,888 -81.4% 0.00% $48K $3.31
2025 Q1 ADDED 78,522 +66,904 +575.9% 0.01% $228K $2.90
2024 Q1 REDUCED 11,618 -41,362 -78.1% 0.01% $49K $4.26
2023 Q3 REDUCED 52,980 -85,165 -61.6% 0.01% $81K $1.53
2023 Q2 ADDED 138,145 +127,175 +1159.3% 0.04% $228K $1.65
2021 Q1 INITIATED 10,970 0.03% $57K $5.20
% of Fund (quarterly)    AQST price (monthly, adj. close)
← Back to XTX Topco Ltd Holdings